Integral Diagnostics Limited (IDX.AX)

AUD 2.9

(-2.68%)

Revenue Summary of Integral Diagnostics Limited

Integral Diagnostics Limited's latest annual revenue in 2024 was 469.69 Million AUD , up 6.73% from previous year.
Integral Diagnostics Limited's latest quarterly revenue in 2024 FY was 469.69 Million AUD , up 6.73% from previous quarter.
Integral Diagnostics Limited reported a annual revenue of 440.09 Million AUD in annual revenue 2023, up 22.68% from previous year.
Integral Diagnostics Limited reported a annual revenue of 358.73 Million AUD in annual revenue 2022, up 2.85% from previous year.
Integral Diagnostics Limited reported a quarterly revenue of 238.44 Million AUD for 2024 Q4, up 3.11% from previous quarter.
Integral Diagnostics Limited reported a quarterly revenue of 469.69 Million AUD for 2024 FY, up 6.73% from previous quarter.

Annual Revenue Chart of Integral Diagnostics Limited (2024 - 2013)

Historical Annual Revenue of Integral Diagnostics Limited (2024 - 2013)

Year	Revenue	Revenue Growth
2024	469.69 Million AUD	6.73%
2023	440.09 Million AUD	22.68%
2022	358.73 Million AUD	2.85%
2021	348.8 Million AUD	27.26%
2020	274.08 Million AUD	17.94%
2019	232.39 Million AUD	22.7%
2018	189.39 Million AUD	5.38%
2017	179.73 Million AUD	7.13%
2016	167.77 Million AUD	10.95%
2015	151.21 Million AUD	3570.22%
2014	4.12 Million AUD	27.55%
2013	3.23 Million AUD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	231.25 Million AUD	3.05%
2024 Q4	238.44 Million AUD	3.11%
2024 FY	469.69 Million AUD	6.73%
2023 Q2	215.7 Million AUD	21.01%
2023 FY	440.09 Million AUD	22.68%
2023 Q4	224.39 Million AUD	4.03%
2022 Q2	180.49 Million AUD	1.35%
2022 FY	358.73 Million AUD	2.85%
2022 Q4	178.24 Million AUD	-1.25%
2021 Q2	170.71 Million AUD	20.0%
2021 Q4	178.09 Million AUD	4.33%
2021 FY	348.8 Million AUD	27.26%
2020 FY	274.08 Million AUD	17.94%
2020 Q4	142.25 Million AUD	7.91%
2020 Q2	131.82 Million AUD	13.01%
2019 Q4	116.64 Million AUD	1.13%
2019 FY	232.39 Million AUD	22.7%
2019 Q2	115.34 Million AUD	20.37%
2018 Q4	95.82 Million AUD	2.4%
2018 Q2	93.57 Million AUD	2.65%
2018 FY	189.39 Million AUD	5.38%
2017 Q4	91.15 Million AUD	2.92%
2017 FY	179.73 Million AUD	7.13%
2017 Q2	88.57 Million AUD	2.86%
2016 Q4	86.11 Million AUD	5.46%
2016 Q2	81.65 Million AUD	1.11%
2016 FY	167.77 Million AUD	10.95%
2015 Q4	80.75 Million AUD	14.62%
2015 FY	151.21 Million AUD	3570.22%
2015 Q2	70.45 Million AUD	0.0%
2014 FY	4.12 Million AUD	27.55%
2013 FY	3.23 Million AUD	0.0%

Peer Revenue Comparison of Integral Diagnostics Limited

Name	Revenue	Revenue Difference
Australian Clinical Labs Limited	689.72 Million AUD	31.901%
BCAL Diagnostics Limited	3.09 Million AUD	-15060.813%
Genetic Signatures Limited	9.76 Million AUD	-4709.513%
Genetic Technologies Limited	7.66 Million AUD	-6027.987%
Healius Limited	1.74 Billion AUD	73.102%
Imagion Biosystems Limited	1.36 Million AUD	-34247.707%
INOVIQ Ltd	535.11 Thousand AUD	-87674.472%
Microba Life Sciences Limited	12.09 Million AUD	-3784.986%
Monash IVF Group Limited	254.96 Million AUD	-84.224%
Rhythm Biosciences Limited	1.69 Million AUD	-27690.354%
Sonic Healthcare Limited	8.93 Billion AUD	94.743%